Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. The company's key products include Enbrel (etanercept) for rheumatoid arthritis and psoriasis, Neulasta (pegfilgrastim) for neutropenia, and Repatha (evolocumab) for hypercholesterolemia. As a leader in the biotechnology industry, Amgen's treatments improve the lives of millions of patients worldwide.
S&P 500 closing prices, top movers, and sector performance — delivered daily.